ACTIVATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH SARCOIDOSIS - VISUALIZATION OF SINGLE-CELL ACTIVATION PRODUCTS
P. Pantelidis et al., ACTIVATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH SARCOIDOSIS - VISUALIZATION OF SINGLE-CELL ACTIVATION PRODUCTS, Thorax, 49(11), 1994, pp. 1146-1151
Background - Interstitial lung diseases are characterised by the recru
itment of mononuclear cells to disease sites where maturation occurs a
nd activation products, including lysozyme (LZM), are released. Analys
is of in vitro cell culture supernatants for activation products masks
the functional heterogeneity of cell populations. It is therefore nec
essary to examine the secretion of activation products by single cells
to assess whether the activation of newly recruited mononuclear phago
cytes at the sites of disease in the lung is uniform and controlled by
the local microenvironment. Methods - The reverse haemolytic plaque a
ssay was used to evaluate, at a single cell level, the ability of bron
choalveolar lavage (BAL) fluid from seven patients with sarcoidosis to
activate Ficoll-Hypaque-separated peripheral blood mononuclear cells
by comparison with BAL fluid from six normal volunteers and nine patie
nts with systemic sclerosis. Monolayers of peripheral blood mononuclea
r cells and sheep red blood cells were cultured either alone or in the
presence of 20% (v/v) BAL fluid with a polyclonal anti-LZM antibody.
LZM/anti-LZM complexes bound to red blood cells surrounding the secret
ing cells were disclosed following complement lysis of red blood cells
and quantification of plaque dimensions using microscopy and image an
alysis. Results - Bronchoalveolar lavage fluid from all the patients w
ith sarcoidosis increased LZM secretion by peripheral blood mononuclea
r cells compared with unstimulated mononuclear cells. By contrast, BAL
fluid from the other individuals had no effect on LZM secretion. Conc
lusions - Single cells activated by BAL fluid can be evaluated by the
reverse haemolytic plaque assay. BAL fluid from patients with sarcoido
sis, but not from patients with systemic sclerosis or normal individua
ls, contains components capable of activating mononuclear phagocytes t
o secrete lysozyme.